There is no reasonable context where we can raise more money without suffering a massive dilution. With a failed trial to prove the merit of the drug, what reason does the market have to put a $ value on this ? What does apabetalone actually cure or help with ? We still do not have an answer, this is absurd and i am eternally disappointed by the management